Rational design of nasal vaccines
- 1 January 2008
- journal article
- review article
- Published by Taylor & Francis in Journal of Drug Targeting
- Vol. 16 (1) , 1-17
- https://doi.org/10.1080/10611860701637966
Abstract
Nasal vaccination is a promising alternative to classical parental vaccination, as it is non-invasive and, in principle, capable of eliciting strong systemic and local immune responses. However, the protective efficacy of nasally administered antigens is often impaired because of delivery problems: free antigens are readily cleared from the nasal cavity, poorly absorbed by nasal epithelial cells and generally have low intrinsic immunogenicity. In this review paper, we describe the main physiological hurdles to nasal vaccine delivery, survey the progress made in technological approaches to overcome these hurdles and discuss emerging opportunities for improving nasal vaccines. According to current insights, encapsulation of the antigen into bioadhesive (nano)particles is a promising approach towards successful nasal vaccine delivery. These antigen-loaded particles can be tailor made by supplying them with targeting ligands, adjuvants or endosomal escape mediators to form the desired vaccine that provides long-lasting protective immunity.Keywords
This publication has 192 references indexed in Scilit:
- Uptake of microparticles into the epithelium of human nasopharyngeal lymphoid tissueMedical Molecular Morphology, 2006
- Enhancement of intranasal vaccination in mice with deglycosylated chain A ricin by LTR72, a novel mucosal adjuvantVaccine, 2006
- The basics and underlying mechanisms of mucoadhesionAdvanced Drug Delivery Reviews, 2005
- Negative attitude of highly educated parents and health care workers towards future vaccinations in the Dutch childhood vaccination programVaccine, 2005
- Strong local and systemic protective immunity induced in the ferret model by an intranasal virosome-formulated influenza subunit vaccineVaccine, 2004
- Intranasal immunisation of mice with liposomes containing recombinant meningococcal OpaB and OpaJ proteinsVaccine, 2004
- Intranasal immunization with influenza vaccine and a detoxified mutant of heat labile enterotoxin from Escherichia coli (LTK63)Journal of Controlled Release, 2002
- Intranasal immunization with liposome-formulated Yersinia pestis vaccine enhances mucosal immune responsesVaccine, 2000
- Identification of M-cells in the rabbit tonsil by vimentin immunohistochemistry and in vivo protein transportHistochemistry and Cell Biology, 1995
- Cytochemical analysis of alkaline phosphatase and esterase activities and of lectin‐binding and anionic sites in rat and mouse Peyer's patch M cellsJournal of Anatomy, 1983